Covid T Cell Immune Response (T-SPOT® Test)

 The T-SPOT® COVID test is designed for the qualitative detection of a cell-mediated (T cell) immune response to SARS-CoV-2 in human whole blood.

The T-SPOT® COVID test aids in identifying individuals with an adaptive, or acquired, immune response to SARS-CoV-2, specifically targeting the T cell response. This test can be used alongside serology tests to support the clinical assessment of individuals, such as those who present with suspected COVID-19 but have a negative PCR result. It is complementary to serology.

• The first COVID-19 test to detect a T cell-mediated response to SARS-CoV-2 infection.
• It has been proven to detect evidence of a T cell-mediated immune response to SARS-CoV-2 infection in PCR-positive patients with negative serology test results.
• When complemented by serology (antibody) results, may provide a more comprehensive view of an individual’s immune response to SARS-CoV-2. Using both T cell and serology tests increases the diagnostic yield.

Please note that the content of this website provides general health information and advice. It is not intended to diagnose, treat, prescribe, or substitute for professional medical advice. Always seek the guidance of your physician or another qualified healthcare provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay seeking it because of something you have read on this website. The owners and authors of this website do not accept any responsibility for your health or any medical outcomes resulting from your use of the information contained herein. Use the information provided at your own risk.